Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Meet new Sanford-Burnham CEO Perry Nisen

August 19, 2014 – 10:00 am | Edit Post

Perry Nisen to bring drug development, science skills to La Jolla.

Meet Sanford-Burnham’s new CEO Perry Nisen

August 19, 2014 – 10:00 am | Edit Post

Perry Nisen to bring marketing, science skills to La Jolla.

HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

August 19, 2014 – 3:00 am | Edit Post
HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

HealthQuest Capital, founded last year by Sofinnova Ventures partner Garheng Kong, says it has raised $110 million for its debut fund and already has invested in several medical technology and…

[[Click headline to continue reading.]]

HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

August 19, 2014 – 3:00 am | Edit Post
HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

HealthQuest Capital, founded last year by Sofinnova Ventures partner Garheng Kong, says it has raised $110 million for its debut fund and already has invested in several medical technology and…

[[Click headline to continue reading.]]

HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

August 19, 2014 – 3:00 am | Edit Post
HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

HealthQuest Capital, founded last year by Sofinnova Ventures partner Garheng Kong, says it has raised $110 million for its debut fund and already has invested in several medical technology and…

[[Click headline to continue reading.]]

Salk Institute continues campaign success, raising $68 million in 2014 fiscal year

August 18, 2014 – 5:00 pm | Edit Post

LA JOLLA—The Salk Institute for Biological Studies celebrates another successful year of fundraising with nearly $68 million raised in fiscal year 2014 to support The Campaign for Salk, the Institute’s first-ever capital fundraising campaign.

Salk Institute continues campaign success, raising $68 million in 2014 fiscal year

August 18, 2014 – 5:00 pm | Edit Post

LA JOLLA—The Salk Institute for Biological Studies celebrates another successful year of fundraising with nearly $68 million raised in fiscal year 2014 to support The Campaign for Salk, the Institute’s first-ever capital fundraising campaign.

Celladon Announces Closing of Public Offering of Common Stock

August 18, 2014 – 4:13 pm | Edit Post

Celladon Corp., a San Diego-based biotech company, has announced the closing of its underwritten public offering of 4,600,000 shares of its common stock at $9.50 per share.

Other viruses can harm body like Ebola

August 18, 2014 – 1:38 pm | Edit Post

Four of the most worrisome viral hemorrhagic diseases.

Ebola treatments quickly becomes priority

August 18, 2014 – 1:27 pm | Edit Post

Size of current outbreak raised calls for emergency use of experimental treatments.